Pfizer Inc. (PFE) शेयर — क्या यह अच्छा व्यवसाय है?

Pfizer Inc. (PFE) शेयर — क्या यह अच्छा व्यवसाय है? — InspectStocks

Just reported

Q3 2026 results

From Pfizer's results release of 3 नवंबर 2026; its quarterly report has since been filed.

Revenue
Actual
$16.58B
-0.4% y/y
+10% q/q
Guided
—
No guide given
EPS, GAAP
Actual
$0.56
-9.7% y/y
Guided
—
No guide given

Company outlook

Full year 2026

EPS, adjusted$2.95 – $3.05Raised +3.4%

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.

कमाई कैसे होती है

Sales of its medicines and vaccines95%
Royalties3%
Contract manufacturing and drug ingredients2%
Research and development services0%

आमदनी के हिस्से year ended December 31, 2025, high confidence के अनुमान हैं, किसी दाख़िल रिपोर्ट के आँकड़े नहीं।

मुकाबला किनसे है

क्या बेचती है6

Eliquis
A prescription medicine that helps prevent blood clots and strokes in certain patients. Pfizer shares its development and commercial profits with Bristol Myers Squibb.
Pfizer vaccine portfolio
Vaccines include the Prevnar family for pneumococcal disease, Comirnaty to help prevent coronavirus disease, and Abrysvo for respiratory syncytial virus.
Paxlovid
A prescription medicine used to treat coronavirus disease.

3 और दिखाएँ

Oncology medicines
Cancer medicines include Ibrance for breast cancer, Padcev for bladder cancer, and Xtandi for prostate cancer.
Nurtec ODT and Vydura
Migraine medicines. ODT means orally disintegrating tablet.
Vyndaqel family
Medicines for transthyretin amyloidosis, a disease in which an abnormal protein builds up in the body and can damage the heart or nerves.

कौन खरीदता है4

Wholesalers, which buy prescription medicines for resale to pharmacies, hospitals and other providers.
Retailers, pharmacies, hospitals and clinics, which buy medicines directly for patients or for use in care.
Government agencies and health institutions, which buy vaccines and medicines through contracts or purchasing programs.
Insurers and pharmacy benefit managers, which negotiate rebates and decide which medicines are covered or preferred on their drug lists.

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

1Revenue depends on continued sales of major medicines and vaccines; generic competition after patent or regulatory exclusivity ends can reduce sales.
2Some important products rely on partnerships: Pfizer shares profits from Comirnaty with BioNTech and from Eliquis with Bristol Myers Squibb, among other collaborations.
3Sales depend on wholesalers and other distribution channels, and on insurers and pharmacy benefit managers covering products and setting their place on medicine lists.
4Pfizer buys raw materials from suppliers worldwide and relies on manufacturing sites and supply chains to make and deliver products.

क्या ग़लत हो सकता है

1When patent protection or regulatory exclusivity ends, generic or biosimilar manufacturers can sell lower-priced alternatives. Pfizer says competition can quickly reduce sales of affected products.
2Government price-setting, required rebates and insurer demands can lower the prices Pfizer receives or limit access to its medicines. The Medicare price-negotiation program now sets a price Pfizer must offer for Eliquis.
3Drug development and regulatory approval can fail or change. Pfizer reported that a late-stage study of its investigational cancer medicine sigvotatug vedotin did not meet its main survival goal, and that it withdrew Oxbryta from the United States market after reviewing clinical and registry data.

पूरे वित्तीय विवरण →

Pfizer Inc. के बारे में

Pfizer discovers, tests, manufactures, markets and sells medicines and vaccines around the world. Its products address conditions including cancer, heart and blood-vessel diseases, migraine, infections, immune disorders and rare diseases. It also makes medicines and drug ingredients for other companies and is winding down a research-services business for biotechnology companies.

मुख्यालय: New York City, New York
स्थापना: 1849 (company founded, high confidence)
कर्मचारी: 75,000 (December 31, 2025, high confidence)
सूचीबद्ध: NYSE
वित्त वर्ष का अंत: December 31

Pfizer Inc. की अपनी रिपोर्टों से बना, जो अमेरिकी प्रतिभूति और विनिमय आयोग (SEC) में दाखिल की गईं। आँकड़े जैसे बताए गए, और प्रति-शेयर इतिहास आज के शेयर आधार पर पुनर्गणित। यह एक व्यवसाय का वर्णन है — यह निवेश सलाह नहीं है और न ही कुछ खरीदने या बेचने की सिफ़ारिश।

Just reported

Q3 2026 results

From Pfizer's results release of 3 नवंबर 2026; its quarterly report has since been filed.

Revenue
Actual
$16.58B
-0.4% y/y
+10% q/q
Guided
—
No guide given
EPS, GAAP
Actual
$0.56
-9.7% y/y
Guided
—
No guide given

Company outlook

Full year 2026

EPS, adjusted$2.95 – $3.05Raised +3.4%

Keep exploring

The themes Pfizer is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

The theme it is part of

Highest-graded in Drug Manufacturers General

Graded A or B and worth $2B or more: A first, then the largest.

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

कमाई कैसे होती है

Sales of its medicines and vaccines95%
Royalties3%
Contract manufacturing and drug ingredients2%
Research and development services0%

मुकाबला किनसे है

क्या बेचती है6

Eliquis
A prescription medicine that helps prevent blood clots and strokes in certain patients. Pfizer shares its development and commercial profits with Bristol Myers Squibb.
Pfizer vaccine portfolio
Vaccines include the Prevnar family for pneumococcal disease, Comirnaty to help prevent coronavirus disease, and Abrysvo for respiratory syncytial virus.
Paxlovid
A prescription medicine used to treat coronavirus disease.

3 और दिखाएँ

Oncology medicines
Cancer medicines include Ibrance for breast cancer, Padcev for bladder cancer, and Xtandi for prostate cancer.
Nurtec ODT and Vydura
Migraine medicines. ODT means orally disintegrating tablet.
Vyndaqel family
Medicines for transthyretin amyloidosis, a disease in which an abnormal protein builds up in the body and can damage the heart or nerves.

कौन खरीदता है4

Wholesalers, which buy prescription medicines for resale to pharmacies, hospitals and other providers.
Retailers, pharmacies, hospitals and clinics, which buy medicines directly for patients or for use in care.
Government agencies and health institutions, which buy vaccines and medicines through contracts or purchasing programs.
Insurers and pharmacy benefit managers, which negotiate rebates and decide which medicines are covered or preferred on their drug lists.

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

1Revenue depends on continued sales of major medicines and vaccines; generic competition after patent or regulatory exclusivity ends can reduce sales.
2Some important products rely on partnerships: Pfizer shares profits from Comirnaty with BioNTech and from Eliquis with Bristol Myers Squibb, among other collaborations.
3Sales depend on wholesalers and other distribution channels, and on insurers and pharmacy benefit managers covering products and setting their place on medicine lists.
4Pfizer buys raw materials from suppliers worldwide and relies on manufacturing sites and supply chains to make and deliver products.

क्या ग़लत हो सकता है

1When patent protection or regulatory exclusivity ends, generic or biosimilar manufacturers can sell lower-priced alternatives. Pfizer says competition can quickly reduce sales of affected products.
2Government price-setting, required rebates and insurer demands can lower the prices Pfizer receives or limit access to its medicines. The Medicare price-negotiation program now sets a price Pfizer must offer for Eliquis.
3Drug development and regulatory approval can fail or change. Pfizer reported that a late-stage study of its investigational cancer medicine sigvotatug vedotin did not meet its main survival goal, and that it withdrew Oxbryta from the United States market after reviewing clinical and registry data.

पूरे वित्तीय विवरण →

Pfizer Inc. के बारे में

मुख्यालय: New York City, New York
स्थापना: 1849 (company founded, high confidence)
कर्मचारी: 75,000 (December 31, 2025, high confidence)
सूचीबद्ध: NYSE
वित्त वर्ष का अंत: December 31

Q3 2026 results

Revenue

EPS, GAAP

Company outlook

कमाई कैसे होती है

मुकाबला किनसे है

क्या बेचती है6

कौन खरीदता है4

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

क्या ग़लत हो सकता है

Pfizer Inc. के बारे में

Q3 2026 results

Revenue

EPS, GAAP

Company outlook

Keep exploring

The theme it is part of

Highest-graded in Drug Manufacturers General

Grade rose recently in Healthcare

कमाई कैसे होती है

मुकाबला किनसे है

क्या बेचती है6

कौन खरीदता है4

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

क्या ग़लत हो सकता है

Pfizer Inc. के बारे में

Keep exploring

The theme it is part of

Highest-graded in Drug Manufacturers General

Grade rose recently in Healthcare

Big pharma

Pfizer Inc.

वृद्धि और नकदी — 5 में से 4

कारोबार का रुझान

समय के साथ शेयर भाव और ग्रेड

Q3 2026 results

Revenue

EPS, GAAP

Company outlook

कमाई कैसे होती है

मुकाबला किनसे है

क्या बेचती है6

कौन खरीदता है4

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

क्या ग़लत हो सकता है

Pfizer Inc. के बारे में

Q3 2026 results

Revenue

EPS, GAAP

Company outlook

Keep exploring

The theme it is part of

Highest-graded in Drug Manufacturers General

Grade rose recently in Healthcare

कमाई कैसे होती है

मुकाबला किनसे है

क्या बेचती है6

कौन खरीदता है4

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

क्या ग़लत हो सकता है

Pfizer Inc. के बारे में

Keep exploring

The theme it is part of

Highest-graded in Drug Manufacturers General

Grade rose recently in Healthcare

Big pharma

Pfizer Inc.

पिछला प्रदर्शन

वृद्धि और नकदी — 5 में से 4

कारोबार का रुझान

समय के साथ शेयर भाव और ग्रेड